A large study on the effects of semaglutide strongly suggests it protects people from myocardial infarction and cerebrovascular accident beyond the weight loss benefits it provides! It may be as significant as statins have been in reducing heart disease!
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection
New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe the medicine is over four years of use.
www.yahoo.com